Fluidigm Corporation (NASDAQ: FLDM) and athenahealth (NASDAQ:ATHN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.
This is a summary of current ratings and target prices for Fluidigm Corporation and athenahealth, as reported by MarketBeat.
||Strong Buy Ratings
Fluidigm Corporation currently has a consensus price target of $9.00, indicating a potential upside of 49.50%. athenahealth has a consensus price target of $141.77, indicating a potential upside of 9.82%. Given Fluidigm Corporation’s stronger consensus rating and higher probable upside, research analysts plainly believe Fluidigm Corporation is more favorable than athenahealth.
Risk and Volatility
Fluidigm Corporation has a beta of 3.37, meaning that its share price is 237% more volatile than the S&P 500. Comparatively, athenahealth has a beta of 1.76, meaning that its share price is 76% more volatile than the S&P 500.
Institutional and Insider Ownership
88.6% of Fluidigm Corporation shares are held by institutional investors. 4.7% of Fluidigm Corporation shares are held by insiders. Comparatively, 3.2% of athenahealth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Fluidigm Corporation and athenahealth’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Valuation and Earnings
This table compares Fluidigm Corporation and athenahealth’s revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
athenahealth has higher revenue and earnings than Fluidigm Corporation. Fluidigm Corporation is trading at a lower price-to-earnings ratio than athenahealth, indicating that it is currently the more affordable of the two stocks.
athenahealth beats Fluidigm Corporation on 8 of the 13 factors compared between the two stocks.
Fluidigm Corporation Company Profile
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.
athenahealth Company Profile
athenahealth, Inc. provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet. The Company has a range of network-enabled services to support healthcare providers across the continuum of care. The Company offers various combinations of its services to its clients, including athenaOne and athenaOne for Hospitals and Health Systems, depending on whether they are medical groups and practices or hospitals and larger health systems. As of December 31, 2016, the Company connected care across a national network of approximately 88,000 providers and approximately 86 million patients. Its suite of network-enabled services includes athenaCollector, athenaClinicals, athenaCommunicator, athenaCoordinator, Population Health and Epocrates.
Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.